JP2009526794A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526794A5
JP2009526794A5 JP2008554654A JP2008554654A JP2009526794A5 JP 2009526794 A5 JP2009526794 A5 JP 2009526794A5 JP 2008554654 A JP2008554654 A JP 2008554654A JP 2008554654 A JP2008554654 A JP 2008554654A JP 2009526794 A5 JP2009526794 A5 JP 2009526794A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
independently
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008554654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526794A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/001213 external-priority patent/WO2007093365A2/en
Publication of JP2009526794A publication Critical patent/JP2009526794A/ja
Publication of JP2009526794A5 publication Critical patent/JP2009526794A5/ja
Pending legal-status Critical Current

Links

JP2008554654A 2006-02-15 2007-02-13 新規なアミノアルコール置換アリールチエノピリミジノン、それらの製造方法及び薬剤としてそれらの使用 Pending JP2009526794A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006007049 2006-02-15
PCT/EP2007/001213 WO2007093365A2 (en) 2006-02-15 2007-02-13 Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments

Publications (2)

Publication Number Publication Date
JP2009526794A JP2009526794A (ja) 2009-07-23
JP2009526794A5 true JP2009526794A5 (https=) 2010-04-02

Family

ID=38069213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554654A Pending JP2009526794A (ja) 2006-02-15 2007-02-13 新規なアミノアルコール置換アリールチエノピリミジノン、それらの製造方法及び薬剤としてそれらの使用

Country Status (13)

Country Link
US (1) US8853208B2 (https=)
EP (1) EP1987042B1 (https=)
JP (1) JP2009526794A (https=)
KR (1) KR20080096670A (https=)
CN (1) CN101384605A (https=)
AR (1) AR059520A1 (https=)
AU (1) AU2007214710A1 (https=)
BR (1) BRPI0707870A2 (https=)
CA (1) CA2636879A1 (https=)
IL (1) IL193342A0 (https=)
TW (1) TW200801022A (https=)
UY (1) UY30164A1 (https=)
WO (1) WO2007093365A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2018380T3 (pl) * 2006-05-19 2012-05-31 Abbvie Bahamas Ltd Skondensowane azabicykliczne pochodne alkanowe podstawione bicykloheterocyklem o aktywności wobec OUN
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
AU2010276441B2 (en) * 2009-07-21 2015-07-02 Gilead Sciences, Inc. Inhibitors of Flaviviridae viruses
WO2011031669A1 (en) 2009-09-09 2011-03-17 Gilead Sciences, Inc. Inhibitors of flaviviridae viruses
US8524764B2 (en) 2010-01-15 2013-09-03 Gilead Sciences, Inc. Inhibitors of Flaviviridae viruses
MX2012008211A (es) 2010-01-15 2012-08-08 Gilead Sciences Inc Inhibidores de virus flaviviridae.
HUP1100241A3 (en) 2011-05-06 2013-12-30 Richter Gedeon Nyrt Oxetane substituted pyrimidones
PT2734515E (pt) 2011-07-13 2016-03-11 Gilead Sciences Inc Derivados de ácido tiofen-2-carboxílico úteis como inibidores de vírus flaviviridae
US8759544B2 (en) 2012-08-17 2014-06-24 Gilead Sciences, Inc. Synthesis of an antiviral compound
US8927741B2 (en) 2012-08-17 2015-01-06 Gilead Sciences, Inc. Synthesis of an antiviral compound
US8841340B2 (en) 2012-08-17 2014-09-23 Gilead Sciences, Inc. Solid forms of an antiviral compound
SG11201804901WA (en) 2015-12-22 2018-07-30 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
EA201992780A1 (ru) 2017-06-21 2020-06-02 ШАЙ ТЕРАПЬЮТИКС ЭлЭлСи Соединения, которые взаимодействуют с суперсемейством ras, для лечения рака, воспалительных заболеваний, ras-опатий и фиброзного заболевания
US12391705B2 (en) 2018-12-19 2025-08-19 Shy Therapeutics, Llc Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
AU2002360387B2 (en) * 2001-11-13 2008-08-07 Emisphere Technologies, Inc. Phenoxy amine compounds and compositions for delivering active agents
DE10233817A1 (de) * 2002-07-25 2004-02-12 Aventis Pharma Deutschland Gmbh Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10238865A1 (de) * 2002-08-24 2004-03-11 Boehringer Ingelheim International Gmbh Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
AU2003287880A1 (en) * 2002-12-11 2004-06-30 7Tm Pharma A/S Cyclic quinoline compounds for use in mch receptor related disorders
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP2007509158A (ja) * 2003-10-23 2007-04-12 グラクソ グループ リミテッド 肥満、糖尿病、うつ病及び不安を治療するためのmchr1アンタゴニストとしての3−(4−アミノフェニル)チエノピリミド−4−オン誘導体
CN1930126A (zh) * 2004-03-05 2007-03-14 万有制药株式会社 吡啶酮衍生物
WO2005103039A1 (en) * 2004-04-15 2005-11-03 Neurocrine Biosciences, Inc. 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists

Similar Documents

Publication Publication Date Title
JP2009526794A5 (https=)
JP2009526792A5 (https=)
JP2009526793A5 (https=)
JP2009526795A5 (https=)
RU2008136898A (ru) Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств
CY1120342T1 (el) Ανταγωνιστης πολυκυκλικου lpa1 και χρησεις εξ' αυτου
US8461191B2 (en) Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
KR101605151B1 (ko) 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드
ES2573715T3 (es) Ligandos sigma para la prevención y/o el tratamiento del vómito inducido por la quimioterapia o la radioterapia
JP2006501202A5 (https=)
RU2007120454A (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
CN104487429A (zh) 杂环黄酮衍生物、组合物及与其相关的方法
RU2624446C2 (ru) Трициклические соединения, композиции, содержащие указанные соединения, и их применения
JP2012523395A5 (https=)
BR112020010429A2 (pt) uso de agonista de kor em combinação com agonista de mor na preparação de fármaco para tratamento da dor
RU2011145054A (ru) Кристаллические формы саксаглиптина
RU2009135016A (ru) Твердые формы, содержащие (-)-о-десметилвенлафаксин, и их применения
BRPI0519287A2 (pt) derivados de amida
ES2820511T3 (es) Ureas asimétricas p-sustituidas y usos médicos de las mismas
TW201536295A (zh) σ配體在與間質性膀胱炎/膀胱疼痛綜合徵(IC/BPS)相關的疼痛的預防和治療中的應用
CO6430439A2 (es) Agonistas del receptor de esfingosina -1- fosfato
JP2023500857A (ja) 新規な化合物およびそれを含むがんの予防または治療用薬学組成物
US20180042922A1 (en) Compositions and methods of treating a neurodegenerative disease
ES2992773T3 (en) Use of thyroid beta-agonists
ES2665293T3 (es) Compuesto para tratar estados con mediación alfa-adrenérgica